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Abstract 
 
Nitrite reductase (NiR) is a bacterial enzyme that catalyzes the one electron reduction of 
nitrite (NO2
-
) to nitric oxide (NO). Through site-directed PCR mutagenesis, variants of 
the electron transfer protein azurin (See figure) were rationally designed to mimic Nitrite 
Reductase (NiR) in an attempt to increase our knowledge about enzyme function and 
design. Several variants were created by incorporation of a Type 2 copper center on the 
surface of the protein. Further mutations were added to aid in electron transfer as well as 
to match the potential of the Type 1 copper in azurin to that of the Type 1 copper in NiR. 
Each variant was characterized using EPR, UV-Vis and mass spectroscopy. Finally, we 
characterized each variant using Michaelis-Menten kinetics. This activity was determined 
using the Griess assay, which allows us to spectrophotometrically quantify the amount of 
nitrite in our reaction. We compared the activity of our NiR models. The results show 
that the variant designed for faster electron transfer did not increase the activity of our 
enzyme, but did increase activity when added with the other mutations. The two variants 
designed to decrease the reduction potential of the Type 1 copper site were found to 
increase the activity by themselves, but decrease the activity when combined. 
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Chapter 1: Introduction 
1.1 Nitrite Reductase and its Role in the Nitrogen Cycle: 
Nitrogen is the fifth most plentiful element in our solar system and comprises 
approximately 78% of Earth’s atmosphere.1   Nitrogen is essential for life on Earth and is 
most commonly found in the form of N2.
1
  N2 is an inert form of nitrogen that must be 
converted into ammonia, NH3, or nitrate, NO3
-
, before it can be utilized by biological 
organisms.
1
  Because of the abundance of the inert form of nitrogen, as well as the 
requirement that it be converted before use in biological systems, nitrogen availability 
often limits the productivity of many ecosystems and can thus have an impact on the 
carbon cycle as well.
2
  The process of reducing N2 into ammonia is known as nitrogen 
fixation and is achieved by prokaryotes as well as some eukaryotes working in a 
symbiotic relationship with prokaryotes.
1
  N2 can also be converted into ammonia and 
nitrate during lightning storms, however this process contributes less than 10% of what is 
produced by biological systems.
2
  Along with being a necessary part for healthy 
ecosystems, biologically available nitrogen can also sometimes have negative impacts. 
Nitrates have the ability to leech through the ground into water sources, altering fresh and 
salt water ecosystems, depleting minerals and acidifying soils.
2
  Reactive oxides of 
nitrogen also have the capability of contributing to acid rain by the formation of nitric 
acid when released as gasses.
2
    
In biological systems, the reduction of one molecule of nitrogen gas into two 
molecules of ammonia is an 8 electron process that requires 16 ATP’s and is only known 
to be achieved by one enzyme, nitrogenase.  Although nitrogenase is common among 
prokaryotes, most organisms obtain ammonia either directly or via the reduction of 
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nitrates to ammonia by either dissimilatory nitrate reduction or through denitrification 
and then nitrogen fixation (see Figure 1).  The main focus of the research presented in 
this thesis was on a mimic of an enzyme found in the pathway of denitrification. 
Specifically the enzyme catalyzing the step in denitrification where nitrite (NO2
-
) is 
reduced to nitric oxide (NO), known as nitrite reductase (See Figure 1). 
 
 
 
Figure 1 - Major biological nitrogen pathways as well as the enzymes associated with each step.  NiR – 
nitrite reductase, NoR – nitrous oxide reductase, Hao – hydroxylamine monooxygenase, Amo – 
ammonium monooxygenase, Nif – nitrogenase.  (Adapted from Canfield
1
) 
 
 
 
Figure 2 – The steps of the denitrification pathway. 
 
Nitrite reductases (NiR) are a family of enzymes with two broad classes: one 
catalyzes the reduction of nitrite through an iron heme site, and the other is a copper 
protein with two types of copper sites that give rise to it its function.  Both enzymes 
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catalyze the reduction of nitrite to nitric oxide, a one electron step in the denitrification 
pathway.
3
  The focus of the work in this thesis was to model the structure and function of 
the latter, copper NiR.  To model NiR it was important to identify factors that are 
believed to be important for copper nitrite reductase function.   
The first factors that are important for function are the presence of two copper 
sites and the types of each copper (see Figure 3).   
 
Figure 3 – The Type 1 and Type 2 copper sites of nitrite reductase from Alcaligenes faecalis PDB 
Id: 1AS7. 
 
The first copper site is identified as a copper Type 1 electron transfer site.  These 
sites are well known to have a greatly conserved structure of two nitrogen bonds from 
histidines as well as a highly covalent copper sulfur bond to a cysteine and a weakly 
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bound axial methionine.
3-7
  These sites are found in a wide range of copper proteins and 
give rise to a characteristic blue or green color due to the large intensity of a ligand to 
metal charge transfer from the cysteine to the copper.
8
  This gives rise to two further 
subclasses of NiRs, those called blue NiR and green NiRs that differ in the nature of their 
Type I copper center.  Blue Type 1 copper sites get their color from an approximately 
600 nm absorption band which arises from a S(Cys) pπ → Cu 3       transition.
6,8
  The 
Type 1 copper sites found in green nitrite reductases have a slightly different geometry 
around the copper, giving rise to a S(cys) pσ → Cu 3       transition with an increased 
absorption around 450 nm.
6,8
  The absorption  is due to the strong covalent cysteine 
ligand as confirmed by Mizoguchi in 1992 when the Type 1 site in azurin, which is 
similar in structure to the Type 1 site in NiR, had the cysteine mutated into an aspartic 
acid, which eliminated the absorption band at 600 nm.
9
  
Another distinct characteristic of Type 1 copper sites is their wide range of redox 
potentials and their electron transfer ability.  The Type 1 copper center potential in NiR 
was measured around 255 mV, which is on the lower end of the Type 1 reduction 
potential spectrum, with values ranging from 184 mV in a stellacyanin up to 1000 mV in 
human ceruloplasmin.
10-12
  A d
10
 copper, or Cu(I), has a preferred tetragonal geometry 
and prefers soft/soft interactions such as sulfur binding while d
9
 coppers, or Cu(II) prefer 
a square planar geometry and more hard/hard interactions like binding nitrogen.
8
  The 
Type 1 sites in NiR and other blue copper proteins have more of a mix of the two ligands 
with a distorted tetrahedral geometry that does not change when the protein is either in 
the oxidized or reduced form.  This lack of reorganization upon changing of oxidation 
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states is one of the factors that give rise to the redox potentials of T1 copper sites, as well 
as their ability to quickly transfer electrons.
8,13
  
 The next important aspect in the function of NiR is the second copper site present, 
designated as the Type 2 copper.  The Type 2 copper site is the catalytic center and is 
where nitrite is reduced.  They consist of a copper bound by 3 histidines and a solvent 
molecule, usually water when substrate is not present, in a distorted tetrahedral 
geometry.
3,6,14
  In the presence of substrate, the water is displaced and nitrite binds.  
Although the products of nitrite reduction are known, the exact order of the mechanism is 
still unclear.  One proposed mechanism for reduction is proposed by Adman (See Figure 
4).
16
  In this mechanism, nitrite first binds to the oxidized copper ion.  The oxidized 
copper ion is then reduced by an electron that is transferred from the pre-reduced Type 1 
copper site.  This electron, as well as a proton from a neighboring aspartic acid, is then 
used to reduce nitrite and form nitric oxide as well as a hydroxide ion.  The nitric oxide 
then dissociates and the hydroxide is protonated, returning water to the Type 2 copper 
sites before the process is repeated again.
15
    
6 
 
 
Figure 4 – Proposed mechanism for the reduction of nitrite to nitric oxide.
16
  
 
The above mechanism is supported by Pinho as well as Strange, who both have 
shown through EPR, ligand binding studies and X-ray crystals that nitrite preferentially 
binds to the oxidized Type 2 copper sites before electron transfer from the type one 
copper sites occur.
6,17
    There has been a second mechanism proposed, such as the work 
done by Wijma, where nitrite binding occurs after the reduction of the type two copper 
sites during conditions with low nitrite concentrations and that the mechanism switches to 
binding to the oxidized copper first when higher nitrite concentrations are seen.
3,18
 
The last property of nitrite reductase that is thought to be important for function is 
the peptide backbone that connects the cysteine of the Type 1 copper site to one of the 
histidines of the Type 2 copper site.  This peptide bond can be seen above in Figure 3 
between Cys136 and His 135 in NiR from Alcaligenes faecalis.  This peptide bond is 
proposed to be the pathway which the electron takes when transferred from the type one 
-NO 
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copper site to the Type 2 copper site.
19
  This is predominantly supported by the 
delocalization of the electron on the oxidized type one copper site on the cysteine which 
gives NiR its intense blue or green color, depending on the NiR subtype.
19
    
NiRs are efficient enzymes at producing NO from nitrite. Turnover numbers for 
native NiR’s range from 0.62 s-1 for NiR from Pseudomonas chlororaphis at a pH of 7.0 
up to 1478 s
-1
 for NiR from Alcaligenes faecalis at a pH of 6.0.
3,6
  The activity for NiR is 
pH dependent, as can be seen in Figure 5 below, with typical results of faster rates at 
lower pH since the reduction of nitrite to nitric oxide requires a proton (see Reaction 1).
14
  
 
Figure 5 -  The pH dependence of NiR from Alcaligenes xylosoxidans.
14
 
 
   
                                                                    (1) 
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1.2 Using Azurin as a Model for Nitrite Reductase: 
Azurin is a copper protein containing a single type one copper site, and it is the 
scaffolding we mutated  to make models that mimic the activity of nitrite reductase.  
Azurin is found in the periplasm of a range of bacteria  and has been shown in vitro to be 
a redox partner of nitrite reductase. 
20-23
  Type 1 copper sites, like the one found in azurin 
and NiR, are often involved in respiration and facilitate electron transfer between 
catalytic sites and other electron donors.
24
  Azurin is 14 kDa in size and consists of 128 
amino acids arranged in a β-barrel structure which is configured in a double wound Greek 
key topology with two beta sheets and a 13 residue long alpha helix.
25,26
   
In addition to the role of azurin in the electron transfer pathway, it has also been 
shown in vitro to interact with p53, a tumor suppressor found in multicellular 
organisms.
27,28
  In these cases, azurin has been found to have the ability to enter cancer 
cells and form complexes with p53.  This then raises p53 levels within the cell and leads 
to an increase in the production of reactive oxygen species which in turn induce apoptosis 
of the cell.
27,28
    
Our modeling of the native NiR’s activity was achieved by making various 
mutations to this blue copper protein azurin.  Azurin already has a Type 1 copper center 
that consists of two histidines, a methionine and a cysteine, as well as a weak interaction 
with the carbonyl from a nearby glycine forming a pseudo trigonal bipyramidal 
geometry.
7,29
  This Type 1 copper is comparable to the Type 1 copper center in NiR's, 
having a similar geometry, UV-Vis spectra and also comparable EPR parameters (see 
Tables 4-7 within the EPR results).  There are a few differences between azurin and 
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native NiR, however, one being the reduction potential of the Type 1 copper.  The redox 
potential of NiR’s Type 1 copper site is about 250 mV, whereas the redox potential of the 
Type 1 copper in azurin is around 357 mV.
6,7,10,12,24,30
  Another difference between azurin 
and NiR is the lack of a Type 2 copper site in azurin, which must be added to the surface 
of the protein.  Both of these differences give us an opportunity to rationally design 
mutations into azurin which we hypothesize to result in comparable nitrite reductase 
activity of the two enzymes. 
1.3 The Parent Azurin-NiR Variants: 
 There were four “parent” variants that were previously created to take care of one 
of the factors that would make the azurin model mimic NiR.
8
  This was the incorporation 
of a second copper binding site on the surface of azurin, with the four designed variants 
named PHM, PHM3His, NiR and NiR3His.  The Type 2 copper sites in PHM and 
PHM3His were originally designed to structurally mimic the copper M sites of peptidyl 
α-hydroxylating monooxygenase, but since they resemble  the Type 2 site in native NiR  
they were also tested for their activity in reducing nitrite.  The models NiR and NiR3His 
were designed to specifically recreate the Type 2 site found in native NiR. 
 The PHM Type 2 copper site was designed by incorporating a methionine on one 
strand and two histidines on an adjacent strand, both of which were located on the surface 
of the protein and approximately 12 Å from the Type 1 copper site.  The mutations that 
achieved this were Gln8Met, Gln14His, and Asn16His.  The PHM3His variant was 
designed using the same mutation sites, except Gln8 was mutated to a histidine instead of 
a methionine.  The NiR and NiR3His variants were designed in a similar fashion, with 
10 
 
NiR having a histidine incorporated into one strand and an aspartic acid and histidine on 
a neighboring strand in the same area of the protein as the PHM variants.  The specific 
mutations were Asn10His, Gln14Asp and Asn16His.  NiR3His used the same mutation 
sites with the difference being a Gln14His mutation instead of the Gln14Asp.
31
   An 
example of one of the incorporated Type 2 sites, in NiR3His azurin is shown in Figure 6.  
 
 
  
Figure 6 – The Type 2 copper site as designed for NiR3His.  This is the same relative position of the Type 2 
site for all four of the parent variants. 
 
1.4 The Three Variants of Parent Mutant NiR3His azurin: The “Second Generation” 
Variants 
 As is discussed in Chapter 3, the activity of these variants was measured.  The 
most active variant was NiR3His.  In order to further increase the nitrite reductase 
activity of this and our other models, there were three residues which were selected for a 
“second generation” of mutations.  These sites were Phe114, Met121 and Phe15.  The 
T2  
 
                             Asn16His 
Gln14His  
 
 
 
                        Asn10His 
 
12 Å 
T1  
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positions of each of those relative to the Type 1 copper site and the designed Type 2 site 
are shown below in Figure 7. 
 
 
Figure 7 – The positions of the three residues that were mutated in the 2
nd
 generation variants (red, 
yellow and green) shown in relation to the Type 2 copper (blue residues) site for NiR/NiR3His. 
 
In addition to adding a second copper, there was also the need to lower the redox 
potential of the Type 1 copper center in azurin from approximately 360 mV to 250 mV in 
order to match that of the Type 1 copper in native NiR.  There were two ways that this 
was achieved; the first was the mutation of the residue Phe114 to a proline.  This 
mutation eliminates a hydrogen bond between Phe114 and Cys112 which then allows 
Cys112 to move closer to the Type 1 copper increasing electron density (shown in Figure 
8).
7
  When Cys112 is closer to the type 1 site it increases the electron density on the 
copper and reduces the reduction potential by about 100 mV.
7
   
 
12 
 
 
Figure 8 – The mutation of Phe114 into Pro114 for the NiR3His model. 
 
A second way that the redox potential of our models was adjusted was with the 
Met121Gln variant which was designed to lower the potential of the Type 1 copper center 
in azurin by about 100 mV.
7
  This mutation changes the axial ligand Met121 to a 
glutamine and, similar to the Phe114Pro mutation, has the effect of disrupting a hydrogen 
bond between Phe114 and Cys112.
7
   
 
 
Figure 9 – The mutation of M121 into Gln121 for the NiR3His model. 
13 
 
 
The third and final “second generation” variant was designed to aid in the transfer 
of an electron between the type 1 copper and the type 2 copper, similar to what the 
peptide bond between His135 and Cys136 accomplishes for native NiR, shown in Figure 
10.  To do this, Phe15 was replaced with a tryptophan due to the known ability of 
tryptophan to aid in long range electron transfer.
32
  Similar work was done by Gray who 
showed a tryptophan residue can help facilitate and speed the transfer of an electron at 
distances of over 20 Ǻ.32 
 
 
Figure 10 – The mutation of Phe15 into Trp15 for the NiR3His model. 
 
After all three of these 2
nd
 generation variants had been created individually, the 
mutations were doubled and tripled on top of each other creating variants such as 
NiR3His Phe15Trp; Phe114Pro and NiR3His Phe15Trp; Phe114Pro; Met121Gln. This 
14 
 
was done to see what effects doubling and tripling of these mutations on top of each other 
had on our models ability to mimic native nitrite reductase. 
The characterization of these variants using EPR and UV-Vis spectroscopy will 
be covered in chapters 3 and 4.  Chapter 5 will discuss the initial kinetic results for the 
activity of a select few of these variants in reducing nitrite.  Chapter 2 will discuss the 
methods used for purifying and preparing samples as well as the experimental methods 
used for activity assays. 
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2.1 Creating New Variants: Mutagenesis: 
 New variants were created by adding second and third mutations to azurin 
variants that had been previously prepared, such as taking the NiR3His Phe15Trp variant 
and adding the Met121Gln mutation to it creating the NiR3His Phe15Trp Met121Gln 
double variant.  This was performed using Stratagene QuikChange© site-directed 
mutagenesis.  These variants were created for all four of the parents to create 16 new 
variants total. 
 After Stratagene QuikChange© site-directed mutagenesis reaction, plasmid 
copying by the DNA polymerase  was confirmed by an agarose gel with the product 
against a 1 kb ladder as shown below in Figure 11.   
 
Figure 11- The product of the Stratagene QuikChange© site-directed mutagenesis for the variants NiR3His 
F15WF114P, NiR3His F15WM121Q and NiR3His F114PM121Q respectively.  Shown is one large band at 
around 4.7 kb as well as a band below 0.5 kb which is due to digestion of the product by Dpn1 which cuts 
methylated DNA and is also due to excess primers in the reaction.   
 
 Restriction digest sites were also previously designed into the primers to either 
add or remove restriction enzyme cut sites.  The two restriction enzymes utilized were 
SmaI and PstI.    When the variants with multiple mutations were created, these 
16 
 
restriction digest sites were unaffected, allowing the use of previous restriction enzymes 
for the new variants.  As an example, variants containing the Phe114Pro mutation used 
the enzyme SmaI.  The enzyme SmaI could then be used for the variants containing 
Phe114Pro+Phe15W as well as the variant Phe114Pro+Met121Gln.  
Variants supposed to contain the Phe114Pro mutation were digested using the SmaI 
restriction enzyme.  The mutation of Phe114Pro removed a cut site for SmaI and changed 
the cut pattern from 2 bands located at 3.2 kb and 1.1 kb for the template plasmid without 
the mutation, to 1 band located at 4.7 kb for plasmids with the mutation.  A positive result 
can be seen in figure 12 below, where lanes 2 and 3 are successful mutations and lane 4 is 
the un-mutated template. 
 
Figure 12- The creation of NiR F15WF114P DNA was initially confirmed in this miniprep digest.  Lane 1 is 
the ladder, lane 2 and 3 are DNA miniprep samples digested with SmaI and lane 4 is the NiR3His F15W 
template DNA also digested with SmaI. 
 
Variants supposed to contain the Met121Gln mutation were digested using the PstI 
restriction enzyme.  This mutation added a cut site for PstI and changed the cut pattern 
from 1 band located at 4.7 kb for the template plasmid without the mutation to 2 bands 
located at 4.3 kb and 0.4 kb for plasmids with the mutation.  A typical positive result can 
10.0 kb 
8.0 kb 
 
6.0 kb 
5.0 kb 
4.0 kb 
 
3.0 kb 
 
2.0 kb 
 
1.5 kb 
1.0 kb 
0.5 kb 
 
4.7 kb 3.2 kb 
1.1 kb 
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be seen in figure 13 below with lanes 2-4 plasmids with the mutation and lanes 5 and 6 
the template plasmid without the mutation.  
 
Figure 13 – Cut pattern of a PstI digest.  Lanes 2,3 and 4 are variants that contain the M121Q mutation 
and were digested with PstI.  Lanes 5 and 6 are the template DNA cut and then uncut respectively.  In the 
lanes with the M121Q mutation, a 400bp band is clearly seen while there is no such band in the template 
DNA, confirming the presence of the M121Q mutation. 
 
The pET9a plasmid that the azurin gene is located in contains a kanamycin resistance 
gene which allows for preferential growth and selection of successfully transformed cells 
in both the XL1-Blue E. coli., as well as the BL21* (DE3) E. coli..  After DNA was 
produced with the QuickChange © mutagenesis process, it was then transformed into 
XL1-Blue E. coli..  Since XL1-Blue E. coli. do not contain a resistance to the antibiotic 
kanamycin and our plasmid does, transformation products were grown on LB plates 
containing the antibiotic kanamycin.  This allowed for the selective culture of only cells 
that had taken in our plasmid DNA.  XL1-Blue E. coli. were then utilized to produce 
large amounts of our plasmid DNA. This was accomplished with the IBI Midi Fast Ion 
Plasmid kit. Typical yields of 250 ng/uL of pure plasmid DNA was obtained. This DNA 
was then checked again using the same restriction enzymes as before to confirm that the 
correct plasmid was present.     
10.0 kb 
8.0 kb 
 
6.0 kb 
5.0 kb 
4.0 kb 
 
3.0 kb 
 
2.0 kb 
 
1.5 kb 
1.0 kb 
0.5 kb 
 
4.3 kb            4.7 
kb 
0.4 kb 
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 Final confirmation that the DNA had the correct mutations was accomplished by 
Sanger sequencing performed by the University of Minnesota BioMedical Genomics 
center.  This was performed for all variants and typical results translated from nucleotides 
into amino acids are shown below in Figure 14.  
 
 
Figure 14 – The amino acid sequence alignment for the midiprep DNA of NiR3His F15WM121Q, 
performed by the software program CLC Viewer. WT sequence is the top row labeled WT Azurin Protein tf 
+1, NiR3His F15WM121Q is labeled SMB2 tf + 1.  Bars below the sequence visualize where mutations have 
occurred. 
 
 
Figure 14 above shows how the sequence results were interpreted.  The top row of 
residues labeled “WT Azurin Protein tf + 1” corresponds to the amino acid sequence of 
wild type azurin.  The second row is the experimental Sanger sequencing results for our 
NiR3His Phe15Trp Met121Gln model.  Azurin starts at amino acid number 21 in the 
figure, with the first 20 amino acids being a leader sequence responsible for directing 
transport of the protein into the periplasmic space when the genes are expressed using E. 
coli..
20
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Once positive confirmation that the correct mutations are in place, the DNA was 
transformed into BL21* (DE3) E. coli., where again the kanamycin resistance imparted 
by the pET9a plasmid allows for selective growth on kanamycin LB –agar plates of cells 
that have taken in our plasmid DNA.  The BL21* (DE3) E. coli. infected with our 
plasmid were then used to express the desired protein with the help of a T7 promoter 
induced by IPTG.  The protein was then extracted from the cells via osmotic shock and 
purified using SP and Q sepharose ion exchange columns. 
 
2.2 UV-Visible Absorption Spectroscopy Sample Preparation:  
All proteins were expressed in BL21* E. coli. and purified as apo protein. In order to 
populate the azurin models with copper a titration was performed. To populate both 
copper centers in our models we used the following procedure. Apo protein had 5 
equivalents of copper sulfate, added 1 equivalent at a time with stirring over ice.  The 
sample was then left to sit for 20 minutes on ice to ensure complete binding of the copper 
to the protein.  The now copper bound protein then had its buffer exchanged into 50 mM 
ammonium acetate at a pH of 5.1 buy running it through a PD-10 size exclusion column, 
packed with Sephadex G-25 M, 1 mL at a time and the blue fraction collected.  The 
protein was then brought to a concentration of 200 µM and an absorbance spectrum was 
collected on a Shimadzu UV-2401 PC UV-Vis spectrophotometer.  Since the Type 1 
copper site has an absorptivity of 100 times that of the Type 2 copper site, only the Type 
1 copper is observed for these samples.  Spectra were measured of the Type 1 copper for 
all parent and second generation variants.   
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To create Type 2 copper only azurin samples, we first populated the Type 1 copper site 
with a Hg(II) ion. Samples were prepared by addition of 1.5 equivalents of HgCl2 to a 
sample of greater than 500 µM apo protein and the A280 nm was determined.  The protein 
was then run through a PD-10 size exclusion column packed with Sephadex G-25 M and 
equilibrated with 50 mM ammonium acetate at a pH 5.1 and collected in three drop 
fractions.  The fractions containing an A280 nm peak were then collected and the 
concentration of the protein was estimated based on the amount of dilution of the A280 nm 
peak.  If the protein was less than 500 µM it was concentrated using a 3000 NMWL 
Ultracell® YM membrane Centricon centrifugal filter device until it was greater than 500 
µM.  Less than one equivalent of copper was then added to the protein and the 
absorbance spectrum was measured.  Spectra have only been measured of the Type 2 
copper centers the parent variants so far.  It should be noted that the absorptivity for Type 
2 copper centers is typically less than 100 M
-1
cm
-1
 for each of the parents, so a 250 µM 
sample has an absorbance of less than 0.05.  Also that the apo protein has a slight 
baseline absorption so a spectra of the apo protein needs to be subtracted.   
 
2.3 EPR Spectroscopy Sample Preparation and Parameters: 
EPR samples were all prepared to incorporate only a Type 1 copper, a Type 2 copper or 
both a Type 1 and Type 2 copper.  To get a spectrum for both the Type 1 and the Type 2 
copper, 5 equivalents of CuSO4 was added slowly over ice with gentle stirring.  This 
consisted of adding 1 equivalent over a period of 1 minute, 5 times.  The sample was then 
let to sit for 20 minutes to ensure complete copper binding.  The copper bound sample 
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was then run down a PD-10 size exclusion column packed with Sephadex G-25 M 1mL 
at a time and the blue fraction was collected.  The collected fraction was then 
concentrated to 2 mM and in a volume of 150 µL using a Millipore 3000 NMWL 
Ultracell® YM  Centricon centrifugal filter device.  This 150 µL was then mixed into 150 
µL of glycerol and vortexed quickly before being tranferred into EPR tubes with a 
syringe and nylon needle, and flash frozen in liquid N2.  To get a signal from only the 
Type 1 copper site, 0.75 equivalents of copper sulfate was added instead of the 5 
equivalents used for the Type 1 and Type 2 copper sample. The rest of the procedure was 
the same. 
To make samples with only the Type 2 copper center populated, 1.5 equivalents of HgCl2 
was added to occupy the Type 1 copper site and prevent copper from binding.  After 
adding mercury, the sample was let sit for 20 min on ice to ensure complete binding.  
After 20 minutes the sample A280 nm was recorded before passing through a PD-10 size 
exclusion column similar to the copper bound samples.  With mercury bound in the Type 
1 site no blue color is observed.  Because of this 3 drop (approximately 150 μL) fractions 
were collected in 25 vials and each checked for A280 nm.  Only samples with an A280 nm of 
more than 0.25 A.U. were kept.  These fractions were then combined and the total 
concentration was based on the total A280 nm, comparing the final A280 nm to the initial A280 
nm and using this ratio to calculate the new concentration.  This sample was then 
concentrated using a Millipore Centricon to a final volume of 150 µL and a final 
concentration of 2 mM.  This 150 µL was then mixed with 150 µL of glycerol and 0.5 
equivalents of CuSO4 was added so that copper could then bind to the unoccupied Type 2 
22 
 
copper site.  Finally the solution was syringed into an EPR tube and flash frozen into 
liquid N2.   
EPR spectra were measured for all of the parent and second generation variants.  Samples 
were run at 77 K on a Varian E-Line Century Series X-band EPR spectrometer.  The 
frequency was set to 9.27 GHz with a center field of 3000 gauss.  A field sweep of 1600 
gauss was taken over 60 seconds with 2 scans averaged per spectra.  A wait time of 10 
seconds was set between scans with the modulation amplitude set to 5 and a time 
constant of 0.032.  Fifteen spectra were taken for each variant and averaged for 
simulation using Simpow 6.   
2.4 Griess and Reoxidation Assay Sample Preparation: 
Apo protein was titrated with copper by slow addition of 5 equivalents of CuSO4 while 
mixing with a stir bar on ice. Initially, one equivalent was estimated via the protein’s 
absorbance at 280 nm with an absorptivity of 8440 M
-1-
cm
-1
.  A small aliquot of apo 
protein is removed, usually around 100 µL, and 
1
/10 to 
1
/4 equivalent (based on the A280nm 
and ε = 8440 M-1cm-1) of CuSO4 is added stepwise and the absorbance max located at 
around 625 nm (variant dependent) is monitored. When addition of CuSO4 yields no 
further increase in the ~625 nm maximum, the exact concentration of protein is 
determined based on the ~625 nm peak and an absorptivity of 5000 M
-1-
cm
-1
. From this 
concentration, 5 equivalents of copper sulfate is determined.  It should be noted that 2 
equivalents of the 5 equivalents of Cu(II) are required to fully bind Cu(II) to the protein, 
since a single Cu(II) is required for each of the type one and type two sites. The excess of 
Cu(II) is used to ensure full saturation (3 equivalents beyond the 2 equivalents needed).  
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After the addition of copper sulfate, the protein is run through a PD-10 column, in a 
volume of no more than 1 mL at a time, to exchange the buffer into 20 mM phosphate at 
a pH of 6.35 as well as to remove any excess copper that is unbound to protein.  The 
concentration of this holo protein is determined again using the absorbance maximum at 
~625 nm.  Finally the protein is diluted to a concentration of  
100 µM in 260 µL and is aliquoted out into screw cap vials and flash frozen in liquid N2. 
These samples give a final protein concentration of 86 µM after addition of 30 µL of 
nitrite and 10 µL of ascorbate to begin the assay.  
 
2.5 Griess Assay Methods: 
For Griess assays, previously prepared protein samples were brought into the glove box 
approximately 20 min before the assay began and left to sit and stir with the lid open to 
thaw and achieve anaerobic conditions and to also let the temperature equilibrate up to 
room temperature.  After this time, 30 µL of varying nitrite concentrations were added 
(see Table 1 for exact amounts and concentrations).  The sample was mixed for 5 minutes 
by stir bar to ensure complete mixing of nitrite in the sample.  Initial data points were 
removed and reacted with Griess reagents before the addition of ascorbic acid to confirm 
that the right amount of nitrite was added and that the right concentration of nitrite was 
present.  Then 10 µL of 1 M ascorbic acid was added (final concentration of 33 mM) to 
reduce the protein and initiate the reaction and data points were collected every 10 – 15 
min (see Table 1) until a ~5% decrease in nitrite was observed (which is the same as a 
5% decrease in the A540 of the Griess reaction).  Data points were obtained by removing 
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20 µL from the reaction vessel and diluting them into buffer, various dilutions were used 
based on the concentration of nitrite present in the sample (see Table 1 below).  For all 
assays except the 2, 5 and 10 mM NO2
-
, the final nitrite concentration before Griess 
reaction was no more than 40 µM, which gives a final absorbance of at most 0.7 A.U..  
However, for the 2, 5 and 10 mM NO2
-
 samples it was too complicated to dilute to the 
same reacted concentration of nitrite, so 20 µL of the reaction mixture was only diluted 
into 480 µL of buffer and then reacted with Griess reagents.  This yields nitrite 
concentrations before the Griess reaction of 80, 200 and 400 µM nitrite.  These must then 
be diluted down after the reaction to get into a reasonable absorbance for measurement 
(see Table 1).  This is possible because even at the highest concentration, the 10 mM 
nitrite with a reacted concentration of 400 µM nitrite, the NED is still in ~10 times excess 
and the SAN is in ~145 times excess (2.88E-5 moles SAN, 1.93E-6 moles NED and 2E-7 
moles NO2
- 
).  There also remains a linear trend in the absorbance observed up to the 10 
mM nitrite starting concentration which has a reacted nitrite concentration of 400 µM as 
shown in Figure 15. 
 
Figure 15 – The calibration plot for Griess assay absorbance vs. nitrite concentration for [NO2
-
] of 1-10 
mM. 
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After the nitrite was diluted to a concentration that would yield an appropriate 
absorbance, a volume of 500 µL of the diluted sample was reacted with 500 µL of 
sulfanilic acid (SAN).  This was vortexed briefly (about 3-4 seconds) and then 500 µL of 
N-(1-naphthyl)ethylenediamine (NED) was added and the mixture was vortexed again for 
5 seconds.  
 
 
Figure 16- Griess reaction scheme.  
 
 
Care must be taken to add the NED as quickly as possible after adding SAN since the 
presence of ascorbate can inhibit color formation after SAN is added through the reaction 
of ascorbate with the diazonium salt (see Figure 17).  This was shown by Moody with 
their graph demonstrating A540 nm and the delay between SAN and NED additions in the 
presence of ascorbate, which resulted in a loss of over 75% of possible color formation 
after 20 minutes.
33
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Figure 17 – The effect of time delay between the addition of SAN and NED to nitrite samples containing 
ascorbate.  The white circles correspond to a sample that contained a 160 µM concentration of ascorbate, 
which is ~ 200 times lower concentration then is present in our assays.
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 This mixture of the assay solution with Griess reagents was then left to sit for 10 
minutes to ensure complete color formation was attained before the absorbance was 
taken.  Samples have been shown to achieve full color formation in as little as 6-7 
minutes and the color stays for up to 30 minutes for all samples except the methods used 
in the 5 mM and 10 mM nitrite assays.  For the 5 mM and 10 mM nitrite samples, 
precipitants are formed if the undiluted reacted Griess sample is left to sit for longer than 
~20 minutes.  A wait of 10 minutes was used between the reaction and absorbance 
measurements to ensure that each trial was consistent.  The azo dye formed has a 
maximum absorption at 540 nm and no absorption at 700 nm, so data points were taken 
as the difference between the peak at 540 nm and the absorbance at 700 nm.   
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Table 1 –  dilutions and NO2
-
 additions 
Nitrite 
Concentration 
Dilutions Nitrite addition 
and time between 
data points 
1 mM 20 µL of rxn assay was diluted into 480 µL of buffer and then reacted with 
Griess reagents and the absorbance taken after 10 min. 
30 µL of 10 mM NO2
- First 
point removed at 2 min, 
then every 10 min starting 
at 10 min 
2 mM 20 µL of rxn assay was diluted into 480 µL of buffer and then reacted with 
Griess reagents.  After 10 min for color evolution, 500 µL of this was then 
diluted into 500 µL of buffer and the absorbance taken. 
30 µL of 20 mM NO2
- First 
point removed at 2 min, 
then every 10 min starting 
at 10 min 
5 mM 20 µL of rxn assay was diluted into 480 µL of buffer and then reacted with 
Griess reagents.  After 10 min for color evolution, 200 µL of this was then 
diluted into 800 µL of buffer and the absorbance taken. 
30 µL of 50 mM NO2
- First 
point removed at 2 min, 
then every 10 min starting 
at 10 min 
10 mM 20 µL of rxn assay was diluted into 480 µL of buffer and then reacted with 
Griess reagents.  After 10 min for color evolution, 100 µL of this was then 
diluted into 900 µL of buffer and the absorbance taken. 
30 µL of 100 mM NO2
- First 
point removed at 2 min, 
then every 10 min starting 
at 10 min 
25 mM 20 µL of rxn assay was diluted into 480 µL of buffer and then vortexed for 
10 s.  20 µL of this was then taken and diluted into another 480 µL of 
buffer and reacted with the Griess reagents.  After 10 min for color 
evolution the absorbance was taken. 
30 µL of 250 mM NO2
- First 
point removed at 2 min, 
then every 15 min starting 
at 15 min 
50 mM 20 µL of rxn assay was diluted into 980 µL of buffer and then vortexed for 
10 s.  20 µL of this was then taken and diluted into another 480 µL of 
buffer and reacted with the Griess reagents.  After 10 min for color 
evolution the absorbance was taken. 
30 µL of 500 mM NO2
- First 
point removed at 2 min, 
then every 15 min starting 
at 15 min 
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100 mM 20 µL of rxn assay was diluted into 980 µL of buffer and then vortexed for 
10 s.  20µL of this was then taken and diluted into another 980 µL of 
buffer and vortexed for 10 s.  From this, 500 µL of sample was removed 
and pippeted into the waste and the remaining solution was reacted with 
the Griess reagents.  After 10 min for color evolution the absorbance was 
taken. 
30 µL of 1 M NO2
- First 
point removed at 2 min, 
then every 15 min starting 
at 15 min 
150 mM 20 µL of rxn assay was diluted into 980 µL of buffer and then vortexed for 
10 s.  20 µL of this was then taken and diluted into another 980 µL of 
buffer and vortexed for 10 s.  From this, 500 µL of sample was removed 
and pipeted into the waste and the remaining solution was reacted with 
the Griess reagents.  After 10 min for color evolution the absorbance was 
taken. 
30 µL of 1.5 M NO2
- First 
point removed at 2 min, 
then every 15 min starting 
at 15 min 
 
The Griess assay was performed for all four of the parent variants.  It was determined that 
NiR3His had the highest activity for nitrite reduction, so the second generation NiR3His 
variants of NiR3His Phe15Trp, NiR3His Phe114Pro and NiR3His Met121Gln were the 
next three targeted for assays.  The other variants will be assayed at a later time.  After 
determining the rate of nitrite reduction for each variant and concentration of nitrite, the 
SigmaPlot 12.5 enzyme kinetics function was used to determine Km and Vmax values.   
 
2.6 Reduction and Reoxidation Assay Methods: 
 Samples were prepared using the same method described above for the Griess 
assay and with the same concentration, however, samples were aliquoted into 2 mL 
volumes or greater because a larger cuvette was necessary to properly stir the sample.  
Before bringing the sample into the glove box, samples were degassed with argon for  
more than 5 minutes by bubbling in a 15 or 50 mL falcon tube.  Samples were monitored 
at 625 nm every 2 seconds over approximately 90 minutes.  The first step was to reduce 
the protein using ascorbate.  This usually required around 2 equivalents of ascorbate 
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based on the concentration of the protein.  After the protein was fully reduced, nitrite was 
added to final concentrations that ranged from 1 mM to 150 mM.  The rate of reoxidation 
was determined by finding the linear region of reoxidation with the largest slope and an 
R
2
 value as close to 1.00 as possible.  This was usually around 4 or 5 minutes after 
reoxidation began and was linear for about 2 minutes total.  The fits of a reoxidation 
assay are shown in Figure 18.    To date, reoxidation assays have only been completed for 
the parent variant NiR3His. 
 
  
Figure 18 – Using a linear regression line to find the initial rate of reoxidation for a 100 µM NiR3His 
sample containing 50 mM nitrite after reduction with 2 equivalents of ascorbate.  Left is the overall 
reoxidation and right is only the linear portion fit with a regression line. 
 
2.7 Proof of Nitric Oxide production: 
In two separate containers, a 5 mL solution of 0.1 M H2SO4 with 0.3 M FeSO4 and a 0.5 
M NaOH with 0.2 M EDTA were prepared.  Each was degassed with argon before 
transfer to the glove box.  This method was based on the paper recipe for ferric salts of 
Ethylenediaminetetraacetic Acid by Steiner, except all samples were prepared 
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anaerobically to prevent oxidation, which results in a yellow color and a complex that 
will not react with NO.
34
  After being brought into the glove box, 600 µL of the EDTA 
solution was mixed with 400 µL of the FeSO4 solution and put into a cuvette to form 
[Fe(EDTA)]
2-
.  This solution was used to blank the spectrometer.  Next, 1 cc of gas from 
inside the glove box was then injected into the cuvette via syringe with a hypodermic 
needle 5 times.  The spectra were recorded to check if any gas from the glove box 
resulted in a spectral change.  This resulted in the pink spectra shown in Figure 19.  Then, 
a 1 mL solution of 260 µM NiR3His with 100 mM NO2
-
 was put into a sealed anaerobic 
vial with a septa and the reaction was initiated by injection of ascorbic acid to a final 
concentration of 30 mM via syringe.  The reaction was let sit for 2 hours before 1cc of 
the headspace was removed by syringe and bubbled through the [Fe(EDTA)]
2-
 solution, 
the resulting spectra is shown in blue below. 
 
Figure 19 – Pink line is the gas from the glovebox bubbled through the [Fe(EDTA)]
2-
 solution as a control.  
Blue line is the headspace gas from the sealed assay with NiR3His which when compared to the spectra 
given by Tegoni confirms that NO is a product.
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The results are comparable to what was seen by Tegoni in their detection of NO as a 
product of their protein mimic of a Type 2 copper site as seen in Figure 20.
35
 
 
Figure 20 -The above spectra is taken from the Tegoni paper and was used to confirm that 
[Fe(NO)(EDTA)]
2-
 was produced.
35
  The thin line is the spectra of [Fe(EDTA)]
2-
 in 1M citrate buffer, the 
dashed is the spectra after flushing with gas evolved from the reaction and the dark line is the difference. 
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Chapter 3: Enzyme Kinetics 
3.1 Assay Calibrations and Controls: 
The first method used to determine the kinetic activity of our models was the 
Griess assay.  This technique reacts nitrite with sulfanilic acid (SAN) to form a 
diazonium salt.  This salt is then reacted with N-(1-naphthyl)-ethylenediamine (NED) to 
form an azo dye that has an absorbance maximum at 540 nm.
36,37
  As our reaction 
proceeded, aliquots of the sample were removed and reacted with SAN and NED to 
determine the nitrite concentration present.  The nitrite concentration plotted versus times 
gives the initial rate for the loss of nitrite.  When these rates are plotted versus their 
respective nitrite concentrations, the data can be fit with the Michaelis-Menten model 
described by Equation 3, which is derived from Equation 2.   
 
                                            (2)     
                                   
V  =  
       
      
             (3)                                       
To start out, we needed to determine the relationship between the absorbance of 
the Griess assay and the concentration of nitrite present in our samples.  Shown in Figure 
21 is the absorbance of the Griess assay at four different concentration of nitrite, 1, 2, 5 
and 10 mM.  At concentrations above 10 mM nitrite, the azo dye product that formed 
from the Griess reactions precipitated, which led to non linear absorbance results.  We 
therefore developed a procedure of diluting our high nitrite concentration reaction 
kf               kcat 
kr 
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aliquots in buffer to a concentration below 10 mM nitrite before reacting them with the 
Griess reactants.  The slope of the calibration plot (Figure 21) was used to determine the 
concentration of nitrite present in our samples and demonstrates the linear correlation 
between the absorbance at 540 nm and the concentration of nitrite present for samples 
between 1 and 10 mM nitrite. 
 
Figure 21 – Calibration plot for the absorbance of the Griess reagents over a range of nitrite 
concentrations 
 
It was also necessary to confirm that any decompositions of nitrite observed was 
due to only our enzyme and not any background rate where nitrite is reduced directly by 
ascorbic acid.  To do this, an assay was conducted in a sample containing 20 mM 
phosphate buffer at a pH of 6.35, 100 mM nitrite and 33 mM ascorbic acid.  The results 
are shown in Figure 22 and indicate that the background rate at the very high 
concentration of 100 mM nitrite gives a rate of 0.0002 ± .00011.5 mM A.U./min.  This 
rate is approximately 100 times slower than the rate observed at the same nitrite 
concentration and pH as our NiR3His variant, which led to the conclusion that the 
background reaction is insignificant relative to the protein catalyzed reaction. 
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Figure 22 – Background reaction rate of 100 mM nitrite with 33 mM ascorbic acid in 20 mM 
phosphate buffer at pH 6.35.  The slope of the trendline is in A.U./min  
 
 
 A second control conducted tested our template protein azurin.  For this control a 
sample of wild type azurin was prepared and the activity tested using the Griess assay.  
The results shown below in Figure 23 are reduction rates for wild type azurin at four 
nitrite concentrations.  The lack of activity confirms that the Type 1 copper site in azurin 
has negligible contribution to the reduction of nitrite by itself. 
 
 
Figure 23 – Wild Type type 1 azurin nitrite reductase activity rates.  Sample contained 86 μM azurin, 5-100 
mM nitrite and 33 mM ascorbate in 20 mM phosphate buffer at pH 6.35. 
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Next we needed to determine if the ionic strength of the reaction solution affected 
the rate of nitrite reduction.  This was determined by varying the nitrite concentration and 
adding NaCl to keep the total ionic strength of NaCl in combination with NaNO2 at a 
constant value, and comparing these rates to the rates when no NaCl is present.   As can 
be seen in Figure 24, where the blue line is the Michaels-Menten fit for NiR3His that will 
be described later, and the black dots are assay rates for samples with a 100 mM total 
ionic strength, there appeared to be no loss of activity between samples with and without 
NaCl in the reaction mixture. 
 
Figure 24 – 86 µM NiR3His assayed using the Griess reaction at various nitrite concentrations.  
Samples were in 20 mM phosphate buffer at pH 6.35 with NaCl added for a total ioninc strength of NaCl + 
NaNO2 of 100 mM.  Blue line is Michaelis-Menten fit for assay samples and black dots are samples with 
NaCl to increase the ionic strength. 
 
Since the goal of the Griess assay is to apply Michaelis-Menten kinetic to these 
models, it is also required that the reducing agent be in excess.  This is necessary as it is 
an assumption under the Michaelis-Menten model that the concentration of active, 
reduced enzyme,[E] in Equation 2, remains constant over the entirety of the reaction.
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The only loss of enzyme should be due to the formation of an enzyme-substrate complex, 
[ES], which after either substrate dissociation or product formation and dissociation, 
returns to the reduced active form.   To determine what constituted an excess of 
reductant, a range of ascorbate concentrations, from approximately 16 mM to 60 mM was 
tested in a Griess assay of the NiR3His variant over 1300 minutes.  As can be seen in 
Figure 25, there was no distinguishable difference between any of the concentrations 
used over that time period. Since our assay procedure calls for an initial concentration of 
33 mM ascorbate, it can be concluded that we have ascorbate in excess for our reactions.  
Had ascorbate not been in excess, a faster rate of the nitrite concentration loss would have 
been observed as the concentrations of ascorbate increased. 
 
Figure 25 – Varied ascorbate concentrations in an assay with NiR3His.  Enzyme concentration was 
86 μM with 1 mM nitrite in 20 mM phosphate buffer at pH 6.35. 
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3.2 Griess Assay Michaelis-Menten Results: 
The Michaelis-Menten kinetics for each of the variants was determined by using 
the initial slope of the first 5% loss of nitrite in the reaction mixtures.  An example of one 
assay is  
 
shown in Figure 26, with each data point being an individual aliquot of the reaction 
mixture removed at a given time. 
 
 
Figure 26 – The initial rate of the loss of nitrite in 86 µM NiR3His sample with 50 mM nitrite as 
monitored by the Griess assay.  The sample was reduced with 33 mM ascorbate and in a 20 mM 
phosphate buffer at pH 6.35. 
 
 
Each of these individual assays was repeated in triplicate for the parent variants at 
a range of nitrite concentrations from 1 mM up to 150 mM.  These rates were then plotted 
versus their nitrite concentrations as shown in Figures 27 and 28, and Michaelis-Menten 
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values of Km and Vmax were determined using the Sigma Plots 12.5 enzyme kinetics tool.  
The Km and Vmax values for each parent are shown in Table 2 below. 
 
 
Figure 27 – Michaelis-Menten plots for the NiR and NiR3His parent variants. 
 
 
 
Figure 28 – Michaelis-Menten plots for the PHM and PHM3His parent variants. 
 
 
0.00E+00
5.00E-03
1.00E-02
1.50E-02
2.00E-02
2.50E-02
3.00E-02
3.50E-02
4.00E-02
0 50 100 150 200
R
at
e
 (
m
M
 n
it
ri
te
/m
in
) 
Nitrite (mM) 
NiR3His 
0.00E+00
5.00E-03
1.00E-02
1.50E-02
2.00E-02
2.50E-02
3.00E-02
0 50 100 150 200
R
at
e
 (
m
M
 n
it
ri
te
/m
in
) 
Nitrite (mM) 
NiR 
0.00E+00
5.00E-03
1.00E-02
1.50E-02
2.00E-02
2.50E-02
3.00E-02
0 50 100 150 200
R
at
e
 (
m
M
 n
it
ri
te
/m
in
) 
Nitrite (mM) 
PHM 
0.00E+00
5.00E-03
1.00E-02
1.50E-02
2.00E-02
2.50E-02
3.00E-02
3.50E-02
4.00E-02
0 50 100 150 200
R
at
e
 (
m
M
 n
it
ri
te
/m
in
) 
Nitrite (mM) 
PHM3His 
39 
 
 
 
 
Table 2 – Km and Vmax values for our four parent variants as well as the values for the native NiR from 
Alcaligenes faecalis at a comparable pH of 6.5.
3
 
Variant KM  
(mM Nitrite) 
Vmax  
(mM nitrite / min) 
Turnover Number 
(s-1) 
NiR3His 45 ± 12 4.59*10-2 ± 0.0046 8.90*10-3 
NiR 35 ± 22 2.62*10-2 ± 0.0054 4.37*10-3 
PHM3His 75 ± 22 5.70*10-2 ± 0.019 1.10*10-2 
PHM 36 ± 16 2.85*10-2 ± 0.0044 5.52*10-3 
Native NiR From A. f.3 0.053 ± 5 Not Listed 1046 ± 33 
 
Our four parent variants all produced comparable Km values on the order of 1000 
times greater than that of Alcaligenes faecalis, a native NiR assayed at a comparable pH 
comparable to our system.
3
  This indicates that our parent variant models have a much 
weaker binding affinity for nitrite than that of native NiR's.  The turnover numbers for 
each parent were also 10
6
 times slower that of the native NiR from Alcaligenes faecalis.  
To improve on our models Km and turnover numbers, three additional mutations were 
made to produce the "second generation" variants. 
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3.3 Second Generation Variants Kinetics: 
To improve on Km and Vmax for the four parent variants, the three “second 
generation” mutation sites were designed.  These variants were designed to either lower 
the reduction potential of the Type 1 copper to better match that of native nitrite 
reductase as in the Phe114Pro and Met121Gln variants, or to aid in the transfer of an 
electron from the Type 1 copper to the Type 2 copper as in the Phe15Trp variant as 
mentioned in chapter 1 section 4.  Figure 29 shows the Michaelis-Menten plots for the 
second generation variants of NiR3His with Km and Vmax for each listed in Table 3.  The 
kinetics of second generation variants for the remaining parents are still being 
determined.   
 
 
Figure 29 – MM plots for the three NiR3His second generation variants. 
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Table 3 – Km and Vmax values for the second generation variants. 
Variant KM  
(mM Nitrite) 
Vmax  
(mM nitrite / min) 
Turnover Number 
(s-1) 
NiR3His F15W 46.05 ± 15.66 5.52*10-2 ± 0.0087 1.07*10-2 
NiR3His F114P 52.55 ± 17.40 7.49*10-2 ± 0.0105 1.45*10-2 
NiR3His M121Q 20.00 ± 7.38 3.90*10-2 ± 0.0043 7.66*10-3 
 
 It appears that there was a slight improvement in the Km for the NiR3His M121Q 
variant, decreasing from 45 mM for NiR3His down to 20 mM for NiR3His M121Q, 
indicating twice the affinity for binding substrate.  There was also a 1.5 fold increase in 
the turnover number for the F114P variant of NiR3His compared to the parent NiR3His. 
   While it does appear that these mutations did have a slight effect on the activity of 
our model, they were unable to generate any significant increase in the activity when 
compared to native nitrite reductases.  However, our ability to rationally design a Type 2 
copper center in azurin that yields nitrite reductase activity, albeit much less than the 
native system, gives promising hope that future designs will further improve on our 
models. 
 
3.4 Catalysis and Pseudo-First Order Reoxidation Assays: 
Since the Griess assays followed only the nitrite concentration, it was important to 
know what was happening to our enzymes during the reaction.  In order to get an insight 
into what our enzyme was doing over the course of nitrite reduction, we needed to use as 
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assay which directly monitored the concentration of the oxidized form of our enzyme, 
termed a reoxidation assay.  This assay follows the oxidized form of our Type 1 copper 
sites which has an absorbance maximum at 625 nm.  This absorbance is lost upon 
reduction of the Type 1 copper site into the reduced, Cu(I), form.  The figure below 
shows the absorption at 625 nm of the NiR3His variant as it is repeatedly reduced with 
ascorbate and then allowed to reoxidize in the presence of excess nitrite.  A similar 
procedure was demonstrated by Tegoni for their model of a Type 2 copper center 
designed into a de novo peptide.
35
  Our NiR3His sample was reduced by ascorbate and 
then reoxidized by nitrite 6 times in 500 minutes and regained 100% of its initial 
absorbance after 24 hours (shown as the red square in Figure 30) indicating our model 
can effectively act as a regenerable catalyst.   
 
 
Figure 30 – A 100 µM sample of NiR3His was reduced with 2 equivalents of ascorbate, as indicated by the 
arrows, in the presence of 10 mM nitrite.  After 30-100 min the sample was then reduced again with an 
additional two equivalents of ascorbate.  The red square is the absorbance after letting the sample sit for 
an additional 24 hours.  Samples were under anaerobic conditions in 20 mM phosphate buffer at pH 6.35. 
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  To determine if the reoxidation of the protein is due to nitrite, and not another 
reaction, a reoxidation experiment similar to the one in Figure 30 was performed with 
nitrite added after the sample had been reduced for a period of time as shown in Figure 
31. 
 
 
Figure 31 – 100 µM NiR3His reduced with 2 equivalents of ascorbate indicated at arrow #1 and then 
reoxidized using 500 equivalents (50 mM) of nitrite indicated at arrow #2.  Sample was under anaerobic 
conditions in 20 mM phosphate 6H 6.35. 
  
Above, the sample was reacted with 2 equivalents of ascorbate and allowed to 
fully reduce.  The sample then sat for 30 minutes before nitrite was added.  Had our 
enzyme reoxidized before the addition of nitrite, we would have concluded that our 
protein was being reoxidized by some other means than from nitrite.  An example of this 
is when the reaction mixture is not fully deoxygenated, and then O2 reacts with our Type 
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1 copper center, reoxidizing it without the presence of nitrite.  Additionally, in doing this 
experiment it was noted that the rate at which the protein reoxidizes after the addition of 
nitrite is initially linearly dependent on the concentration of nitrite in the reaction.  This 
means that the reoxidation rates are pseudo-first order, with the reaction being overall 
first order with respect to nitrite.  Shown below is an example of how the rate of 
reoxidation was determined. 
 
 
 
 As a control, a reoxidation assay was performed on wild type azurin.  In this 
assay, wild type azurin was reduced with 2 equivalents of ascorbate.  Nitrite was then 
added (arrow #1 in Figure 32) to a final concentration of 10 mM to see if this would 
induce reoxidation.  When no reoxidation occurred after 100 minutes, one extra 
equivalent of copper was added (arrow #2 in Figure 32) to determine if unbound copper 
in the presence of our reduced protein could also induce reoxidation of our protein by 
nitrite.  Again, no reoxidation occurred for 100 minutes indicating nitrite does not oxidize 
the Type 1 copper site in azurin even in the presence of unbound copper.  This indicates 
that copper bound to the Type 2 copper site is essential for the reoxidation of the Type 1 
copper sites in our models.  
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Figure 32 – Reoxidation assay with 100 µM wild type azurin reduced by 2 equivalents of 
ascorbate.  Arrow 1 indicates the addition of 10 mM nitrite.  Arrow 2 indicates the addition of 1 
equivalent of excess CuSO4.  Sample was under anaerobic conditions and in 20 mM phosphate buffer at 
pH 6.35.  
 
Figure 33 – The initial rate of reoxidation of 100 µM NiR3His in the presence of 50mM nitrite.  Left shows 
the overall reoxidation and right shows  Sample was under anaerobic conditions in 20 mM phosphate 
buffer at pH 6.35. 
 
After samples began to reoxidize, the rate of reoxidation remained linear for 
between 1.5 and 3 minutes and with a high linear correlation as was shown in Figure 33.  
When the rate of reoxidation is plotted versus nitrite concentration, we see a linear trend 
as shown in Figure 34, with the slope being the second order rate constant. 
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Figure – 34 Pseudo first order rates vs. [NO2
-
] for 100 µM NiR3His reduced by 1-2 equivalents of 
ascorbate.  
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Chapter 4: EPR Spectroscopy 
4.1 Characterization of Variants Using EPR:   
One of the ways that copper proteins can be characterized is by using electron 
paramagnetic resonance (EPR) spectroscopy.  EPR spectroscopy can only be used to 
characterize our models in the oxidized form when the Type 1 and Type 2 copper sites 
are occupied by copper in the Cu(II) state.  Cu(II) is a paramagnetic species with a 
[Ar]3d
9
 electron configuration, meaning it has one unpaired electron.  EPR uses a 
magnetic field to split the spin state levels for this unpaired electron into higher and lower 
energy levels as shown in Figure 35.
39
  The splitting of the spin state levels is 
proportional to the magnitude of the magnetic field applied.
39
  When a constant 
microwave frequency is applied to the sample, and the applied magnetic field is scanned 
over a range of intensities, unpaired electrons in the lower energy ms = – ½ level will 
absorb the microwave energy and be transferred to the higher energy ms = + ½ spin 
state.
39
  This occurs when the microwave energy is equal to the energy difference 
between the spin state levels.
39
  The energy of absorption is detected and used to create 
the EPR spectrum.  
Not only does the applied magnetic field cause splitting of the electron spin state 
energies, so does the magnetic field that is generated by the spin of the copper nucleus.  
This causes hyperfine splitting, with the number of levels determined by the equation 2NI 
+ 1, where N is the number of nuclei present in the sample and I is the nuclear spin of the 
paramagnetic species.
39
  These nuclear spin generated energy levels are referred to as mI.  
For example, the Cu(II) atoms in our models have a nuclear spin of 3/2  giving rise to 4 
hyperfine peaks.  
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Figure – 35 representation of the splitting of the electron spin state orbital cause by an externally 
applied magnetic field as well as the magnetic field generated by the nuclear spin of the copper nucleus. 
 
There are two values focused on in our Cu(II) EPR spectrum.  These are the g-
values, the splitting due to the external magnetic field, and the A-values, splitting due to 
the magnetic field generated by the copper nucleus.  The g-value is further split into gx, gy 
and gz, with each applying to a different axis of the copper-ligand bonds.  Since the Type 
1 and Type 2 copper sites on our model both typically exhibit axial symmetry, where the 
x and y-axis are equivalent, the gx and gy parameters are combined and referred to as  .  
The principal z-axis has a g-value referred to as  .  Similar to the g-values, A-values are 
dependent on the symmetry of the system, with axial systems having    for Ax and Ay as 
well as    for Az.  Below in Figure 36 the    and   -values are demonstrated on an 
axial copper EPR spectrum.  The    and    in Figure 36 are located around a g-value of 
2.0, but are difficult to determine without the aid of EPR simulation programs such as 
Simpow 6.  
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Figure 36 – Demonstration of the g-value and A-values parameters of an axial Cu(II) system such 
as the ones on our Type one and Type 2 copper centers. 
 
 Type 1 copper centers typically exhibit relatively small   values of < 80 gauss, 
as in the Type 1 copper of wild type azurin.
40
  The cause of this small hyperfine splitting 
for Type 1 copper centers is derived from the high covalency of the Cu-S(Met) bond. 
8,41,42
  Type 2 coppers typically have   values of between 120-180 gauss.
40
  In Figure 37 
it is demonstrated how the Type 1 and Type 2 copper centers in our copper proteins can 
be measured separately.  Additionally, since these copper sites are electronically 
independent of each other (they do not couple/interact), the resulting spectra are just an 
addition of each copper site. 
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Figure 37 – Type 1 and Type 2 copper EPR spectrum individually as well as a Type 1 and Type 2  
copper spectra demonstrating that the two individual copper spectrums can be added together to give 
the Type 1 plus Type 2 spectrum. 
 
Both the parent as well as the “second generation” variants with single mutations 
of Phe15Trp, Phe114Pro and Met121Gln, had all been previously created and had 
characterized by EPR.  After we created the double and triple mutants for each of the four 
parent variants, we begin characterizing them in order to compare them with our previous 
models.  We took three different types of EPR spectra, one by binding copper to only the 
Type 1 site, another by binding copper to only the Type 2 site and a last spectrum by 
binding copper to both the Type 1 as well as the Type 2 site.  The spectra for all of the 
variants are displayed in Figures 38-41 and the simulated   and   values listed in 
Tables 4-7. 
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Figure 38 – Spectra of all of the PHM Variants 
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Figure 39 – Spectra of all of the PHM3His Variants 
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Figure 40 – Spectra of all of the NiR Variants 
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Figure 41 – Spectra of all of the NiR3His Variants 
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Table 4 -    values Type 1 copper (Gauss) 
 Parent F15W F114P M121Q F15W 
F114P 
F15W 
M121Q 
F114P 
M121Q 
F15W 
F114P 
M121Q 
NiR3His 2.26 2.25 2.21 2.29 2.20 N/A 2.28 2.28 
NiR 2.26 2.25 2.21 N/A 2.20 N/A 2.28 N/A 
PHM3His 2.26 2.26 2.21 N/A 2.20 2.29 N/A 2.27 
PHM 2.26 2.26 2.21 2.29 2.20 2.29 2.27 2.27 
Native 
NiR from 
A. x. 
43
 
2.24        
 
 
Table 5    values Type 2 copper (Gauss) 
 Parent F15W F114P M121Q F15W 
F114P 
F15W 
M121Q 
F114P 
M121Q 
F15W 
F114P 
M121Q 
NiR3His 2.30 2.29 2.29 2.27 2.30 2.28 2.28 2.29 
NiR 2.32 2.30 2.31 2.30 2.30 2.30 2.29 2.30 
PHM3His 2.30 2.30 2.30 2.30 2.30 2.30 2.30 2.30 
PHM 2.30 2.30 2.30 2.30 2.30 2.30 2.30 2.30 
Native 
NiR from 
A. x. 
43
 
2.38        
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Table 6 -    values Type 1 copper (Gauss) 
 Parent F15W F114P M121Q F15W 
F114P 
F15W 
M121Q 
F114P 
M121Q 
F15W 
F114P 
M121Q 
NiR3His 47.14 53.45 61.90 N/A 68.02 N/A 37.77 36.20 
NiR 52.43 51.53 64.95 N/A 66.22 N/A 33.92 N/A 
PHM3His 53.09 53.41 62.54 N/A 68.02 17.56 N/A 36.51 
PHM 53.23 52.83 63.46 20.76 67.27 20.08 39.29 36.51 
Native 
NiR from 
A. x.
43 
63        
 
 
 
Table 7 -    values Type 2 copper (Gauss) 
 Parent F15W F114P M121Q F15W 
F114P 
F15W 
M121Q 
F114P 
M121Q 
F15W 
F114P 
M121Q 
NiR3His 158.04 165.31 159.73 168.15 165.12 167.61 167.85 166.87 
NiR 159.62 161.47 154.32 157.26 155.77 159.97 156.32 160.22 
PHM3His 160.54 162.66 164.45 163.82 163.47 163.82 163.82 163.75 
PHM 165.19 163.80 165.52 164.83 163.47 164.33 163.94 162.63 
Native 
NiR from 
A. x.
43 
127        
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As previously stated, for Type 1 copper centers an   of <80 gauss is expected.  
This is observed for all variants for which simulations have been successfully completed.  
The variants that include the Met121Gln mutation are often difficult to simulate for the 
Type 1 copper centers and some have yet to be fully refined.  The difficulty arises from 
the Met121Gln mutation displaying a much more rhombic spectrum than the other 
variants.  The rhombic spectrum is likely due to a shorter Cu-ligand bond distance for 
Cu-Gln than in Cu-Met as well as an increase of 0.2 Ǻ of the copper out of the axial plane 
defined by the His2Cys ligands.
44
  This could induce rhombic splitting in the EPR 
spectrum by increasing the ligand field strength along the z-axis and increasing the 
amount of dz
2
 character of the HOMO.
8
   
The Type 2 copper centers all display measured   and    values that are within 
the typical range, however there are a few slight differences between variants and 
between our models and the native NiR from Alcaligenes xylosoxidans (AxNiR).  The 
Type 2 copper of AxNiR has a smaller    value than that of our models by about 35 
gauss, indicating a higher degree of covalency of the AxNiR Type 2 copper with the 
histidine ligands.
43
  Between our models, NiR3His, NiR and PHM3His all have 
   values of approximately 160 gauss, with a slight increase to 165 gauss for the PHM 
variant.  The   values for all variants were approximately 2.3 gauss with little variation, 
this is slightly smaller than that of AxNiR, with a   value of 2.38 gauss.
43
 
The results of the EPR measurements and simulations indicate that we have 
successfully maintained the Type 2 copper binding site for the single, double and triple 
variants.  This validates the use of all of the variants as models to mimic the nitrite 
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reductase activity seen in native NiR’s. Furthermore, the Type 1 copper site also remains 
intact but with varying amounts of perturbation that appear to be variant dependent, with 
the largest amount of perturbation of the Type 1 copper site coming from the 
incorporation of the Met121Gln mutation.  These results are consistent with the UV-
Visible absorption spectra for each variant as will be seen in chapter 5.     
 
 
 
 
59 
 
Chapter 5: UV-Visible Spectroscopy 
5.1 Characterization of the Type 1 Copper Sites in the Azurin Model: 
The parent variants were designed to add a second copper binding site on the 
surface of the protein approximately 12 Å from the Type 1 copper site to mimic the 
arrangement of copper in the noncoupled dinuclear copper protein family.  These 
mutations are far enough away from the Type 1 center as to not affect the ligand binding 
environment around the copper.  This can be seen when the UV-visible absorption 
spectra of the parent variants’ Type 1 copper are overlaid with the spectrum for wild type 
azurin as seen in Figure 42.     
 
Figure 42 – The UV- Visible spectra of the four Parent variants and wild type azurin.  Samples 
measured in 50 mM ammonium acetate buffer at pH 5.1. 
 
The Phe15Trp mutation located between the Type 1 and Type 2 sites which was 
designed to aid in electron transfer between the two sites, and does not alter any of the 
ligands of both copper sites, results in little change to the UV-Visible spectra.  Unlike the 
Phe15Trp mutation, the Phe114Pro and Met121Gln mutations are located in positions 
which either directly or indirectly affect the binding ligands of the Type 1 copper site.  
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The Phe114Pro mutation removes a hydrogen bond between Phe114 and Cys112 and is 
thought to allow Cys112 to move closer to the Type 1 copper.
7
  Since the main 
absorption band is a S(Cys) 3p(π) → Cu 3       LMCT, this results in the blue shifting 
of the main peak as well as increases in intensity of a shoulder around 800 nm due to a 
copper d→d transition. 6,8,45 ,46   Mutagenesis studies have shown that the Met121, His46 
and His117 Type 1 copper ligands in azurin are not required for the characteristic blue 
color of the Type 1copper center, with the Cys112 ligand contributing the most to the 
color of the protein.
9
  The Met121Gln mutation replaces the Type 1 methionine ligand 
with a glutamine, also blue shifting the spectra and greatly increasing the absorption of 
the S(Cys) 3p(σ) → Cu 3        LMCT band that is observed around 450 nm.
8
   
 
 
Figure 43 – Result that the F15W, F114P and M121Q mutations have on the UV- Visible spectra.  
Spectra were measured in 50 mM ammonium acetate buffer at pH 5.1. 
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When mutations are doubled and tripled up, the effects of each on the Type 1 
copper signal is additive as seen with the variant NiR3His Phe15Trp Met121Gln.  The 
variant NiR3His Phe15Trp has an absorption maxima at 625 nm, and the variant NiR3His 
Met121Gln has an absorption maxima at 611 nm.  When these mutations are combined to 
create the NiR3His Phe15Trp Met121Gln variant, the absorption maxima is the average 
of the two, at 618 nm. Variants containing the Phe114Pro mutation tend to have an 
increase in the d→d transition observed near 800 nm and Met121Gln variants always 
show an increase in the S(Cys) 3p(σ) → Cu 3      band around 450 nm.  Figures 44–51 
show the Type 1 copper spectra for each variant arranged by parent. 
 
 
Figure 44 – UV-Visible of Type 1 copper site in PHM3His.  Samples were in 50 mM ammonium 
acetate at pH 5.1.   
  
Figure 44 shows an overlay of all variants of the parent PHM3His.  Characteristic 
blue band at approximately 625 nm indicates the retention of the Type 1 copper site.  
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Bands at 450 nm for Met121Gln and 800 nm for Phe114Pro variants also appear and are 
maintained for the double and triple variants. 
 
Figure 45 – Main UV- Visible peaks of PHM3His. Samples were in 50 mM ammonium acetate at 
pH 5.1. 
 
 Figure 45 shows a closer look at the absorption maxima for each variant of the 
parent PHM3His.  The variants containing Met121Gln and Phe114Pro result in the 
largest deviations from the spectrum of the parent variant. 
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Figure 46 – UV- Visible of Type 1 copper site in PHM.  Samples were in 50 mM ammonium 
acetate at pH 5.1. 
 
 Figure 46 shows the variants of the parent PHM.  Again, variants containing the 
mutation Phe114Pro display an increase in the absorption band at 800 nm and variants 
containing the Met121Gln mutation have an increase in the absorption band at 450 nm.   
 
 
Figure 47 – Main UV- Visible peaks of PHM. Samples were in 50 mM ammonium acetate at pH 
5.1. 
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 Figure 47 shows a closer look at the main absorption band for the variants of the 
parent PHM.  The trend of variants containing the mutations Met121Gln and Phe114Pro 
resulting in the largest deviation from the parent variant is still observed. 
 
Figure 48 –  UV- Visible of Type 1 copper site in NiR3His.  Samples were in 50 mM ammonium 
acetate at pH 5.1. 
 
In Figure 48 are the variants of the parent NiR3His.  For the variant NiR3His 
Met121Gln a band appears at ~385 nm, which has previously been assigned to a S(Met) 
b1 → Cu 3      transition for native NiRs.
8
  However, the variant Met121Gln is the 
only variant displaying this band, so it is currently unclear exactly what this transition is 
due to since this variant lacks the methionine ligand.   
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Figure 49 – Main UV- Visible peaks of NiR3His. Samples were in 50 mM ammonium acetate at pH 
5.1. 
 The main blue absorption bands for the variants of NiR3His are shown in figure 
49.  Similar shifts in the absorption maxima are observed for the NiR3His variants when 
compared to the same mutations in the parent variants NiR, PHM and PHM3His. 
 
 
 
Figure 50 –  UV- Visible of Type 1 copper site in NiR.  Samples were in 50 mM ammonium acetate 
at pH 5.1. 
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An absorption band at ~385 nm is again observed for the variant NiRMet121Gln.  
This is similar to the spectra of the variant NiR3His Met121Gln.     
 
Figure 51 – Main UV- Visible peaks of NiR. Samples were in 50 mM ammonium acetate at pH 5.1. 
 
 These spectra demonstrate that the Type 1 copper site is conserved within all of 
the variants which were created.  While there are some slight variations in the spectra as a 
result of differences in the geometry of the Type 1 copper site, this diversity of our 
models will allow us to more deeply explore what affects the kinetics of these variants. 
 
5.2 Characterization of the Type 2 Copper Sites: 
For all variants, UV-Vis spectra were taken of the Type 1copper bound protein 
that also contained a copper in the Type 2 site.  However, since the Type 1 copper has an 
absorptivity of about 100 times that of the Type 2 sites, only the absorption peak due to 
0
0.2
0.4
0.6
0.8
1
1.2
500 550 600 650 700
A
b
so
rb
an
ce
 
Wavelength (nm) 
NiR NiRF15W
NiRF114P NiRM121Q
NiRF15WF114P NiRF114PM121Q
NiRF15WM121Q NiRF15WF114PM121Q
67 
 
Type 1 centers can be observed.  To obtain a spectrum for Type 2 copper centers, the 
Type 1 site must be populated with Hg(II) first before copper is added to the protein.  
Mercury has a higher binding affinity for the Type 1 site due to the presence of sulfur 
ligands found in methionine and cysteine.
13
  The Type 2 center has no sulfur ligands, 
giving it a weak affinity for mercury and leaving it unoccupied for copper to bind.  The 
Type 2 spectra have only been obtained for the parent variants so far and can be seen 
below in Figure 52. 
 
Figure 52 – Absorptivities of the parent Type 2 copper sites.  Spectra taken in 50 mM ammonium 
acetate at a pH of 5.1.  
 
The ɛ we observed for the Type 2 copper centers ranged from 31 M-1cm-1 for 
PHM up to 65 M
-1
cm
-1 
for our NiR3His model with absorbance maxes that ranged from 
677-722 nm (Table 8).  These values are comparable to the absorptivities and absorbance 
maximum that was observed for a de novo designed Type 2 copper center in 2012.
35
  The 
absorbance of the Type 2 copper is attributed to Cu(II) d-d transitions.
35
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Table 8 – Absorptivities and maximum absorbance wavelengths of our parent variants as well as 
a de novo designed Type 2 copper site compared to CuSO4 in solution.  
 Absorptivity 
(M
-1
cm
-1
) 
Absorbance 
Max (nm) 
NiR3His 65 690 
NiR 51 722 
PHM3His 43 715 
PHM 31 677 
CuSO4 24 764 
Cu(II)(TRIL23H)3
2+(8)
 133-138 640 
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Conclusion and Future Directions:  
Nitrogen is an important part of biological systems on Earth and it exists in many 
oxidation states ranging from -3 to +5.  There are many enzymes involved in the 
conversion of nitrogen between these oxidation states.  The work of this thesis was on 
modeling the copper containing nitrite reductases which take part in the reduction of 
nitrite to nitric oxide.  By incorporation of a second copper binding site into the Type 1 
copper electron transfer protein azurin, we were able to model the active site of these 
nitrite reductases.   
 Through the Griess assay and reoxidation assays we were able to show that our 
model enzymes follow Michaelis-Menten kinetics as well as determined the Km and Vmax 
values for our parent and second generation NiR3His variants.  It was also shown that our 
model acts as a catalyst and produces NO as a product.  While the turnover numbers of 
nitrite reduction achieved by our model are ~10
6
 times slower than native systems, we 
still have a few models to test for their reactivity which may yield better results.     
 We also showed through EPR spectroscopy that our models have a second copper 
binding site, and that all but the Met121Gln retain the axial environment around the Type 
1 copper site.  The Met121Gln has a more rhombic environment due to the incorporation 
of a glutamate in the axial position.  Additionally, we were able to characterize all of the 
Type 1 copper sites of our models using UV-Vis spectroscopy.  Parent variants had little 
to no change in their spectra when compared to the wild type azurin, while variant 
containing mutations Phe114Pro and Met121Gln resulted in shifts of the main absorption 
band as well as increases in additional absorption bands.  The F114P variants all resulted 
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in a blue shift of the main LMCT peak from 625 nm down to ~600 nm.  There was also 
an increase in the Cu(II) d→d shoulder at 800 nm.  M121Q seemed to have the largest 
effect on the protein, resulting in a change to a greenish blue color.  This was due to a 
slight blue shift in the main LMCT peak as well as a large increase in the absorption 
bands around 400 nm which are due to the  S(Cys) 3p(σ) → Cu 3      transition. 
 The next steps will be to continue characterizing the remaining variants for their 
nitrite reductase activity. Also, we will seek to design additional variants with the 
intention of increasing the binding affinity of nitrite for the Type 2 catalytic center as 
well as increasing the Vmax.  Finally, we will attempt to also identify additional substrates 
toward which our model may have functional activity towards. 
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